ß2-Adrenoreceptor Agonists, Montelukast, and Parkinson Disease Risk. (2023)

First Author: Liu B

Attributed to: Mental Ageing funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/ana.26638

PubMed Identifier: 36897287

Publication URI: http://europepmc.org/abstract/MED/36897287

Type: Journal Article/Review

Volume: 93

Parent Publication: Annals of neurology

Issue: 5

ISSN: 0364-5134